Drugs / rgp120/HIV-1MN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001041 | ? → Jul 1998 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rgp120/HIV-1MN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001041 ↗ |
| Known as | MN rgp120 | “Pregnant women are randomized to receive an initial injection of MN rgp120 vaccine or alum placebo between week 16 and week 24 of gestation” NCT00001041 ↗ |
| Modality | Vaccine | “rgp120/HIV-1MN vaccine” NCT00001041 ↗ |